Luis Fayad
- Pathology and Forensic Medicine top 5%
- Oncology top 10%
- Genetics top 5%
- Immunology
- Hematology top 10%
- Co-authors
- Susan O’BrienMichael J. KeatingRazelle KurzrockJames M. ReubenBang‐Ning LeeSusan LernerPeter McLaughlinBarbara Pro
- Topics
- Lymphoma Diagnosis and Treatment (24 papers)Chronic Lymphocytic Leukemia Research (17 papers)CAR-T cell therapy research (6 papers)
- Journals
- Journal of Clinical OncologyBloodInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- United StatesAustraliaSingapore
In The Last Decade
Luis Fayad
32 papers receiving 584 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 336
- Oncology 275
- Genetics 227
- Immunology 185
- Hematology 123
Countries citing papers authored by Luis Fayad
This map shows the geographic impact of Luis Fayad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Fayad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Fayad more than expected).
Fields of papers citing papers by Luis Fayad
This network shows the impact of papers produced by Luis Fayad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Fayad. The network helps show where Luis Fayad may publish in the future.
Co-authorship network of co-authors of Luis Fayad
This figure shows the co-authorship network connecting the top 25 collaborators of Luis Fayad. A scholar is included among the top collaborators of Luis Fayad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Fayad. Luis Fayad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 24 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 23 | |
| 14 | 18 | |
| 15 | 10 | |
| 16 | 4 | |
| 17 | 2 | |
| 18 | 3 | |
| 19 | 231 | |
| 20 | Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity. | 11 |
About Luis Fayad
Luis Fayad is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 33 papers that have together received 597 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (17 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Genetics (227 citations), Pathology and Forensic Medicine (336 citations) and Hematology (123 citations). Luis Fayad has collaborated with scholars based in United States, Australia and Singapore. Frequent co-authors include Susan O’Brien, Michael J. Keating, Razelle Kurzrock, James M. Reuben, Bang‐Ning Lee, Susan Lerner, Peter McLaughlin, Barbara Pro, Farzaneh Maadani and Sandra Acholonu. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.